• OPEN AN ACCOUNT
Indian Indices
Sensex
74,828.25 299.17
( 0.40%)
Global Indices
Nasdaq
51,895.24 -174.59
(-0.34%)
Dow Jones
7,786.35 0.65
(0.01%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,716.75 8.42
(0.08%)
Forex
USD-INR
95.81 -0.17
(-0.18%)
EUR-INR
109.93 -0.31
(-0.28%)
GBP-INR
128.18 -0.37
(-0.29%)
JPY-INR
0.61 0.00
(-0.38%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
16.36
14596.56
EPS(TTM)
Face Value()
Div & Yield %
49.8
2
0.61
 

Board of Uflex recommends final dividend
Jun 01,2026
Uflex announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.